model-based design and integration of a two-step biopharmaceutical production process
TRANSCRIPT
ORIGINAL PAPER
Model-based design and integration of a two-stepbiopharmaceutical production process
Bruno Otero • Marcus Degerman • Thomas Budde Hansen •
Ernst Broberg Hansen • Bernt Nilsson
Received: 4 October 2013 / Accepted: 11 March 2014
� Springer-Verlag Berlin Heidelberg 2014
Abstract This paper presents the design of a two-step
process in which the first step is PEGylation of a protein,
and the second step is chromatographic purification of the
target mono-PEGylated protein from the unreacted and the
di-PEGylated impurities. The difference between optimiz-
ing each process step separately and optimizing them
simultaneously is studied. It was found that by optimizing
the steps simultaneously up to a 100 % increase in pro-
ductivity could be obtained without reduction in yield.
Optimizing both steps at the same time makes it possible
for the optimization method to take into account that the di-
PEGylated protein is much easier to separate than the non-
PEGylated protein. The easier separation makes it possible
to get a higher yield and productivity at the same time. The
effect of recycling was also studied and the yield could be
increased by 30 % by recycling the unreacted protein.
However, if maximum productivity is required, batch mode
is preferable.
Keywords Process design � Biopharmaceutical
production � Process integration � Optimization
List of symbols
cA0 Initial concentration of non-PEGylated protein in
the reaction
ci Concentration of component i in the mobile phase
(kmol/m3)
cpool Concentration of mono-PEGylated protein in the
pool (kmol/m3)
cS Concentration of PEG (kmol/m3)
CV Column volumes
Dax Apparent dispersion coefficient (m2/s)
dp Bead diameter (m)
k1 Kinetic constant for side-chain attachment forming
mono-PEGylated protein
k2 Kinetic constant for side-chain attachment forming
di-PEGylated protein
kkin,i Adsorption kinetic rate for component i in the
chromatographic separation (s-1)
Hi Henry’s constant
Pe Peclet number
qi Concentration of component i adsorbed onto the
stationary phase (kmol/m3)
qmax,i The maximum adsorption capacity for component
i (kmol/m3)
rS Ratio between substrate and protein at the start of
the reaction
SP Specific productivity [mg/(h mL)]
t Time from the beginning of the simulation (s)
tR Time for the reaction
v Linear velocity of the bulk flow between the
particles
Vcycle Volume of eluent used in a cycle (L)
Vpool Volume of the pool captured in the
chromatographic purification (L)
VR Reactor volume (L)
x Axial location in the column (m)
B. Otero � M. Degerman � B. Nilsson (&)
Department of Chemical Engineering, Lund University,
Box 124, 221 00 Lund, Sweden
e-mail: [email protected]
M. Degerman
e-mail: [email protected]
T. B. Hansen � E. B. Hansen
Novo Nordisk A/S, Bagsværd, Denmark
123
Bioprocess Biosyst Eng
DOI 10.1007/s00449-014-1174-9
Greek symbols
eC Column void
ep,i Particle porosity for component i
eT Total apparent column porosity
bi Exponential salt coefficient for component i
x Ratio between operating cost and feed cost in the
normalized earnings objective function
Introduction
The biopharmaceutical industry is devoting greater efforts
to understand the processes used, in order to make them
more robust, and to improve yields and overall produc-
tivity. Biopharmaceutical companies were encouraged to
focus on process control and analysis by the PAT initiative
of the US Food and Drug Administration [1]. The ICH has
released several publications demanding a better under-
standing of the products and processes [2, 3], and quality
risk management [4]. A typical biopharmaceutical down-
stream process consists of a number of steps, e.g., chro-
matographic purification and filtration and, in some cases,
modification of the target protein. Chromatographic puri-
fication steps have been extensively studied and optimized
[5–19], but little research has been devoted to optimizing
the process as a whole. When each step is optimized sep-
arately, it is highly probable that a suboptimal operating
space will be found. One of the main challenges in opti-
mizing several steps simultaneously is that an experimental
approach will be very difficult to use, and a model of each
process step is required. However, if the models are com-
plex, the simulation time can be very long, and a balance
must therefore be obtained between model complexity and
simulation time.
Optimization of multiple processing steps and complete
processes has been an active research area in chemical
engineering in decades [20] and has been focused on
steady-state and continuous processes resulting in mixed-
integer nonlinear programming problems, MINLP [21, 22].
Optimization of dynamic operation of process systems has
also been studied [23, 24]. A not so extensively studied
area is optimization of batch processes [25, 26] and recent
studies on integrated batch processes [27].
The formulation of the problem, i.e., defining the
objective function, the decision variables, and constraints,
is the first step in the optimization. It is both the most
important and the most difficult part of the process, as the
decisions made here will have considerable effects on the
final result. In many cases, the aim of process optimization
is to optimize the economy, but it is often difficult to define
an economical objective function. A common solution is,
therefore, to create so-called Pareto fronts between pro-
ductivity and yield [14, 28] or between purity and yield
[29], which provide a graphical tool that can be used to
decide how to run the process.
This study is concerned with the PEGylation of a protein
and its subsequent purification. The target is a mono-
PEGylated protein, which is mixed with low amounts of
unreacted protein and di-PEGylated impurities. The reac-
tion considered is enzymatically catalyzed PEGylation, and
ion-exchange chromatography is used to purify the end
product. The process was optimized with and without
recycling of the non-PEGylated protein in an attempt to
increase the process yield. The optimization of each step
separately, and the optimization of both steps simulta-
neously was compared using Pareto fronts between pro-
ductivity and yield.
Theoretical aspects
Modeling
Reaction model
The reaction model for PEGylation consists of three first-
order irreversible reactions, assuming that interactions only
take place between the substrate and each of the
components:
ocA
ot¼ �k1 � cA � cS � cE ð1Þ
ocD
ot¼ k2 � cB � cS � cE ð2Þ
ocBC
ot¼ k1 � cA � cS � cE � k2 � cB � cS � cE; ð3Þ
where the reaction kinetic constants are denoted k, the
concentrations of the components are denoted c, and the
subscripts A, B, D, S, and E refer to the non-PEGylated
protein, mono-PEGylated protein, di-PEGylated protein,
PEG, and the enzyme, respectively.
Chromatography model
Chromatographic purification is described by the disper-
sion and convection in the mobile phase using a reaction
dispersive model [30]:
oci
ot¼ Dax
o2ci
ox2� v
eT
oc
ox� 1� eC
eT
oqi
ot; ð4Þ
where ci is the concentration of component i in the mobile
phase, qi is the concentration of component i adsorbed onto
the stationary phase, Dax is the dispersion coefficient, eC
the column void, eT the total column porosity, and v the
linear velocity of the bulk flow between the particles.
Bioprocess Biosyst Eng
123
The dispersion coefficient, Dax, is derived from the Pe-
clet number, Pe, [31]:
Pe ¼ v � dp
Dax
ð5Þ
where dp is the bead diameter.
The kinetics governing the adsorption of the particles to
the stationary phase is described by Eqs. 6 and 7 given by
Langmuir’s adsorption model [11, 28]:
oq
ot¼ kkin;i Hi � ci 1�
X
i
qi
qmax i
!� qi
!ð6Þ
Hi ¼Hoi
cbisalt
ð7Þ
where qmax,i is the maximum adsorption capacity for
component i, and Hi is Henry’s constant, which is modified
according to Eq. 7 with the salt concentration, where H0,i is
an experimentally calibrated constant and bi is the protein
binding charge [32].
Optimization
The process is optimized by varying one or more param-
eters, called decision variables, in order to maximize the
objective function. The objective function used in this
study was the normalized earnings (NE) as defined by
Karlsson et al. [28], where x is defined as the ratio between
operating cost and feed cost, SPmax is the maximum spe-
cific productivity obtained when optimizing the NE when
x = 0, and Ymax is assumed to be 100 % (Eqs. 8, 9).
x ¼ FeC
OCþ FeCð8Þ
NE ¼ 1� xð Þ SP
SPmax
þ xY
Ymax
ð9Þ
The definitions of specific productivity (SP) and global
yield (Y) in Eqs. 8 and 9 are given in Eqs. 10 and 11.
SP ¼ cpool � Vpool
Vcycle
ð10Þ
cpool is the concentration of the target component in the pool
obtained during the chromatographic separation, Vpool is the
volume of the pool, and Vcycle is the volume of buffer used in
chromatographic separation cycle; it is calculated as the
volume from the start of the load until the end of the pooling.
SP maximizes how much is produced per how much solvent
is needed for the complete cycle. Vcycle is used instead of time
because minimizing the amount of expensive buffers needed
is often more important than reducing the time of the step.
Y ¼ cpool � Vpool
cA0 � Vr
ð11Þ
cA0 is the concentration of non-PEGylated protein at the
start of the reaction and VR the reactor volume. The yield is
thus defined as the amount in the pool after the purification
divided by how much non-PEGylated protein was added at
the start of the reaction.
Case study
Reaction
The reaction studied was the PEGylation of a model pro-
tein supplied by Novo Nordisk A/S, which has two sites the
PEG molecules can react with. When PEG molecules react
enzymatically with either of these sites, active mono-
PEGylated protein (B/C) is produced, and when PEG reacts
with both sites, di-PEGylated protein (D) is produced,
which has reduced activity [33]:
Aþ S�!k1Bþ S�!k2
D
Aþ S�!k1C þ S�!k2
Dð12Þ
The two mono-PEGylated molecules (B and C) cannot
be distinguished from one another and are considered
analogous. The target product is both B and C and will be
denoted B for the rest of the article.
It is assumed that the reaction is carried out in a batch
reactor containing the native protein, the substrate and the
enzyme. It is assumed that the reactor is loaded with a
batch of 100 g protein, and that the entire contents of the
reactor are loaded onto the column. A typical reaction
profile is shown in Fig. 1.
Fig. 1 Simulation of the enzymatic PEGylation of native protein (A),
mono-PEGylated protein (B) and di-PEGylated protein (D) with
reaction time. A is a solid, B dashed and D a dotted line
Bioprocess Biosyst Eng
123
It can be seen that higher amounts of mono- and di-
PEGylated protein are produced with increasing reaction
time, although the amount of mono-PEGylated protein
decreases slowly if the reaction is allowed to proceed long
enough, due to the reaction of PEG with the second site. The
decision variables varied in the reaction model were initial
protein concentration (cA0), reaction time (tR), and the ratio
between substrate and protein at the start of the reaction (rs).
Purification
The end product is purified by cation-exchange chromatog-
raphy. This method is based on the different charges of the
PEGylated and un-PEGylated proteins. The PEG-molecule
shield the charge on the protein, reducing the adsorption
strength and the proteins elute at a lower salt concentration.
The first to elute is the di-PEGylated protein, followed by the
larger mono-PEGylated protein, and finally the native protein,
which shows the strongest interaction with the cation
exchanger (Fig. 2). Both the mono-PEGylated and the non-
PEGylated protein can be collected where the non-PEGylated
protein can be recycled to increase the yield. This separation is
also the main challenge for the chromatographic step.
The decision variables varied in the purification step are
the length of the salt gradient (VG), the final concentration
of the salt gradient (cSalt,f), and the column load (mLoad).
Recycling
Three different modes of operation were studied.
1. Batch mode A single batch reaction followed by
column separation of the reactor outlet stream.
2. Five-cycle recycling mode Five batch reactions, in
which the unreacted native protein is recycled and
mixed with fresh protein before the reaction step.
After five cycles, the process is stopped and a new
series of reactions is run to avoid the build-up of
degradation products and other impurities. The recy-
cled fraction collected from the chromatography
column is concentrated to the initial feed concentra-
tion prior to mixing with the fresh protein. Ultra-
filtration can be used for concentration and for larger
proteins a higher membrane cut-off will avoid salt
accumulation.
3. Infinite recycling mode In this case, it was assumed
that the process rarely had to be stopped for cleaning.
The batch recycling is run until it has reached steady
state which was then used to compare with the two
other modes.
Simulation
All simulations were performed with a variable-order
differential equation solver (ode15s) in MATLAB [34],
with a relative error tolerance of 0.1 %. The method of
lines [35] was used to discretize the column with 20 grid
points. The first derivative was estimated with a one-for-
ward and three-backward finite difference approximation,
and the second derivative was approximated by a five-
point central finite difference. A Dirichlet boundary con-
dition was used at the column inlet and a homogeneous
Neumann condition at the outlet.
Optimization
The optimization method used was patternsearch in
MATLAB, which is a direct search method [36]. The mesh
tolerance was set to 10-6. To increase the robustness of the
method, MADS (mesh-adaptive search) was activated,
which allowed patternsearch to randomly select the set of
vectors that forms the pattern for each new mesh size.
Pareto front
The optimization problem consists of obtaining the
Pareto front for the three different modes of operation
and optimization approaches. This is done by first
optimizing the maximum specific productivity (x = 0)
and then iterate with increasing values of x, using the
previously found operating point as guess value. The
decision variables are summarized in Table 1, together
with their corresponding bounds, which were used to
ensure that the variables remained between realistic
values.
Fig. 2 Chromatographic purification of di-PEGylated, mono-PEGy-
lated and unreacted protein eluting in this order. The separation was
run at low load at good separation
Bioprocess Biosyst Eng
123
Results and discussion
Process optimization versus step optimization
Normalized earnings were optimized as a function of x, as
explained above. This was done for two cases: the com-
plete process, in which both steps were optimized simul-
taneously, and separate optimization of the reaction and the
chromatographic purification steps. In the first case, the
objective function focused on the output from the purifi-
cation step. In the second case, the reaction was optimized
first, and then the purification step, based on the optimi-
zation of the first step. The results are compared in Fig. 3.
The maximum specific productivity is shown in the figure,
which also gives a minimum yield for the process. Trying
to obtain a lower yield will result in a lower specific pro-
ductivity as well and this part of the graph is not shown as
it is never interesting for design purposes.
Both methods of optimization give yields from about
37 to 67 %, but the specific productivity obtained with
step optimization is, at its worst, 50 % lower than that
obtained by optimizing the whole process. Although the
difference in productivity decreases at higher yields, these
results clearly show that optimizing the two steps sepa-
rately leads to a suboptimal working point. When opti-
mizing the steps separately, the optimal conditions for the
reaction reduce the amount of di-PEGylated produced,
while the amount of unreacted protein is moderate. This
complicates the separation, since the main difficulty lies
in separating the unreacted and mono-PEGylated forms of
the protein, requiring a longer gradient thus a lower
productivity. Optimization of the complete process pro-
vides a balance between the optimal conditions for the
reaction and separation, in which more of the di-PEGy-
lated protein is formed, making purification easier, as the
column yield can be increased giving a higher global
yield. The chromatograms in Fig. 4 obtained with process
optimization (left) and step optimization (right) show the
same global yield, but the productivity was lower with
step optimization. Note the much longer chromatographic
cycle for the step optimal operating point and the lower
concentrations of the peaks.
As explained above, optimization of the complete
process leads to the conversion of almost all the native
protein into either mono- or di-PEGylated protein. This
leads to a decrease in the product yield in the reactor,
but simplifies the removal of the di-PEGylated protein.
The column is loaded so much that the di-PEgylated
goes in flow through and the mono-PEGylated product
requires only a short elution step to elute. With step
optimization, the reaction produces a higher amount of
mono-PEGylated protein, but it is more difficult to
purify, due to the presence of native protein, and a
larger elution volume of 55 L is needed. The decision
variables for the two kinds of optimization can be seen
in Table 2. The ratio of substrate to native protein is
lower in step optimization, which gives a high yield in
the reaction, but makes separation more difficult. The
final salt gradient is lower, the length of the gradient is
increased, and a lower load and thus a larger column are
needed to separate the product.
Batch mode versus recycling mode
A similar analysis was performed to compare the Pareto
fronts obtained from process optimization of the different
recycling modes (Fig. 5).
The maximum productivity obtained was almost
identical in all cases, as can be seen in Fig. 5. This is due
to that to achieve maximum productivity the two recy-
cling modes stopped recycling any non-PEGylated pro-
tein and converted all of it to make the productivity of the
chromatographic purification as high as possible. The
Table 1 Decision variables for the optimization of the enzymatic
reaction and the chromatographic purification step
Decision variable Upper
bound
Reaction Reaction initial concentration (cA0) (g/L) 20
Reaction time (tR) (h) 100
Ratio substrate/protein at start (rS) (-) 2
Column Final salt concentration in gradient (cSalt,f) (mol/L) 1
Gradient length (VG) (CV) 1,000
Load (mLoad) (g/L column) 100
The lower bound for all decision variables is 0
Fig. 3 Pareto front resulting from optimization of the complete
process (solid) and step optimization (dashed) without recycling
Bioprocess Biosyst Eng
123
higher the yield the more recycling is done and at yields
above 60 %, differences become apparent between batch
mode and the recycle modes. The maximum possible
yield obtained with the different processes differs con-
siderably, being 66 % in batch mode and about 86 % in
the recycling modes. At this point almost 50 % of the
non-PEGylated protein is recycled for every batch and at
maximum productivity no recycling is performed at all
making it a batch process again (Fig. 6). Five-cycle
recycling and infinite recycling modes show similar
results, which is due to how quickly the recycling reaches
steady state. This means that a five-cycle recycling will
give the same performance as running infinite recycling
without the risk of build-up of unwanted impurities or
fragmentation of the target protein.
Figure 7 shows chromatograms for optimal cases for
batch mode and five-cycle recycling with similar global
yield and a 10 % difference in productivity. In this case,
the batch mode provides a higher mono-PEGylated protein
yield. It also produces less di-PEGylated protein than the
recycling mode, but this kind of reaction entails slower
separation and, hence, a reduction in productivity. Lower-
yield reactions can be run in recycling mode in order to
obtain better separation, since some of the native protein is
recycled, whereas running only one reaction step and one
Fig. 4 Simulated chromatograms for process optimization (left) and
step optimization (right), at x = 0.2. The vertical black lines show
where the product is pooled. The dotted line shows the salt gradient.
The di-,mono- and non-PEGylated protein is shown with a dashed,
solid and dash–dot line, respectively
Table 2 Decision variables for process optimization and step opti-
mization at 39 % global yield
Process optimization Step optimization
Normalized SP (%) 100.0 49.4
Yield (%) 39.0 39.0
Decision variables
cA0 (g/L) 20.0 20.0
tR (h) 1.9 0.2
rS (-) 1.6 1.1
cSalt,f (mol/L) 1.5 0.8
VG (CV) 0.0 76.0
mLoad (g/L) 85.5 41.9
Fig. 5 Pareto fronts obtained from optimization of batch mode
(solid), five-cycle recycling (dotted) and infinite recycling (dashed)
Bioprocess Biosyst Eng
123
chromatography step gives a better yield, but less efficient
separation.
The values of the decision variables obtained from the
optimization of batch and recycling mode are summarized
in Table 3. It can be seen that batch mode operation
requires a more dilute feed, which means that a larger
volume must be loaded onto the column, and a smaller
substrate:protein ratio, which improves the reaction yield
but entails a longer elution gradient to separate the unre-
acted protein.
Conclusions
This paper presents the optimization of a common
downstream process in the biopharmaceutical industry.
It shows that for this particular case, a simplistic
approach in which the steps are optimized indepen-
dently will lead to suboptimal working points which, in
some cases, can lead to a decrease in productivity of up
to 50 %. The results of this study also show that a
model-based approach is needed to optimize the whole
process, as it would be extremely difficult to optimize
both steps simultaneously using a purely experimental
approach.
Recycling the unreacted protein increases the yield
without significantly affecting the specific productivity. If
maximum productivity is required, batch mode operation
is the preferred choice, while if a compromise can be
accepted between yield and productivity, or if the maxi-
mum yield is required, recycling mode can be used to
improve the performance of the process. Only a small
number of recycling steps (5) is required to obtain a
system working at steady state, which will reduce the
build-up of degradation products and other impurities in
the system.
Fig. 6 For the recycling modes, the amount recycled increases with
increasing global yield. At maximum productivity no recycling is
performed and at maximum yield almost 50 % is recycled during
every batch
Fig. 7 Simulated
chromatograms for optimized
batch mode (left) and for
optimized five-cycle recycling
mode (right) with both 58 %
global yield. The vertical black
lines show where the product is
pooled. The dotted line shows
the salt gradient. The di-,mono-
and non-PEGylated protein is
shown with a dashed, solid and
dash–dot line, respectively
Table 3 Values of decision variables obtained for optimized batch
operation and five-cycle recycling, with global yield at 58 %
Batch mode Recycling
mode
Normalized SP (%) 50.4 64.0
Yield (%) 58.0 58.0
Decision variables
cA0 (g/L) 8.8 20.0
tR (h) 1.8 2.1
rS 1.2 1.4
cSalt,f (mol/L) 0.8 1.0
VG (CV) 84.7 56.0
mLoad (g/L) 49.4 55.0
Bioprocess Biosyst Eng
123
References
1. FDA USFaDA (2004) Guidance for industry PAT—a framework
for innovative pharmaceutical development, manufacturing, and
quality assurance
2. ICH (2009) ICH Q8 pharmaceutical development
3. ICH (2012) ICH Q11 development and manufacture of drug
substances
4. ICH (2005) ICH Q9 quality risk management
5. Degerman M, Jakobsson N, Nilsson B (2007) Modeling and
optimization of preparative reversed-phase liquid chromatogra-
phy for insulin purification. J Chromatogr A 1162(1):41–49.
doi:10.1016/j.chroma.2007.02.062
6. Guelat B, Delegrange L, Valax P, Morbidelli M (2013) Model-
based prediction of monoclonal antibody retention in ion-
exchange chromatography. J Chromatogr A (0). doi:10.1016/j.
chroma.2013.04.048
7. Guelat B, Strohlein G, Lattuada M, Delegrange L, Valax P,
Morbidelli M (2012) Simulation model for overloaded mono-
clonal antibody variants separations in ion-exchange chroma-
tography. J Chromatogr A 1253(0):32–43. doi:10.1016/j.chroma.
2012.06.081
8. Muller-Spath T, Aumann L, Melter L, Strohlein G, Morbidelli M
(2008) Chromatographic separation of three monoclonal antibody
variants using multicolumn countercurrent solvent gradient
purification (MCSGP). Biotechnol Bioeng 100(6):1166–1177.
doi:10.1002/bit.21843
9. Muller-Spath T, Strohlein G, Aumann L, Kornmann H, Valax P,
Delegrange L, Charbaut E, Baer G, Lamproye A, Johnck M,
Schulte M, Morbidelli M (2011) Model simulation and experi-
mental verification of a cation-exchange IgG capture step in
batch and continuous chromatography. J Chromatogr A 1218(31):
5195–5204. doi:10.1016/j.chroma.2011.05.103
10. Carta G, Jungbauer A (2010) Protein chromatography: process
development and scale-up. Wiley, New York
11. Guiochon G, Shirazi DG, Felinger A, Katti AM (2006) Funda-
mentals of preparative and nonlinear chromatography. Elsevier
Academic Press, Amsterdam
12. Degerman M, Jakobsson N, Nilsson B (2008) Designing robust
preparative purification processes with high performance. Chem
Eng Technol 31(6):875–882. doi:10.1002/ceat.200800097
13. Degerman M, Westerberg K, Nilsson B (2009) Determining
critical process parameters and process robustness in preparative
chromatography—a model-based approach. Chem Eng Technol
32(6):903–911. doi:10.1002/ceat.200900019
14. Degerman M, Westerberg K, Nilsson B (2009) A model-based
approach to determine the design space of preparative chroma-
tography. Chem Eng Technol 32(8):1195–1202. doi:10.1002/
ceat.200900102
15. Jakobsson N, Degerman M, Nilsson B (2005) Optimisation and
robustness analysis of a hydrophobic interaction chromatography
step. J Chromatogr A 1099(1–2):157–166. doi:10.1016/j.chroma.
2005.09.009
16. Jakobsson N, Degerman M, Stenborg E, Nilsson B (2007) Model
based robustness analysis of an ion-exchange chromatography
step. J Chromatogr A 1138(1–2):109–119. doi:10.1016/j.chroma.
2006.10.057
17. Westerberg K, Broberg Hansen E, Degerman M, Budde Hansen
T, Nilsson B (2012) Model-based process challenge of an
industrial ion-exchange chromatography step. Chem Eng Technol
35(1):183–190. doi:10.1002/ceat.201000560
18. Westerberg K, Degerman M, Nilsson B (2010) Pooling control in
variable preparative chromatography processes. Bioprocess Bio-
syst Eng 33(3):375–382. doi:10.1007/s00449-009-0335-8
19. Mollerup JM, Hansen TB, Kidal S, Staby A (2008) Quality by
design-thermodynamic modelling of chromatographic separation
of proteins. J Chromatogr A 1177(2):200–206. doi:10.1016/j.
chroma.2007.08.059
20. Chen HS, Stadtherr MA (1985) A simultaneous-modular
approach to process flowsheeting and optimization. Part I: theory
and implementation. AIChE J 31(11):1843–1856. doi:10.1002/
aic.690311110
21. Floudas CA (1995) Nonlinear and mixed-integer optimization.
Oxford University Press, USA
22. Biegler LT, Grossman IE, Westerberg AW (1997) Systematic
methods of chemical process design. Prentice Hall, Upper Saddle
River
23. Biegler LT, Cervantes AM, Wachter A (2002) Advances in
simultaneous strategies for dynamic process optimization. Chem
Eng Sci 57(4):575–593
24. Larsson PO, Akesson J, Carlsson N, Andersson N (2012) Model-
based optimization of economical grade changes for the borealis
borstar polyethylene plant. Comput Chem Eng 46:153–166
25. Srinivasan B, Palanki S, Bonvin D (2003) Dynamic optimization
of batch processes: I. Characterization of the nominal solution.
Comput Chem Eng 27(1):1–26
26. Mendez CA, Cerda J, Grossmann IE, Harjunkoskic I, Fahlc M
(2006) State-of-the-art review of optimization methods for short-
term scheduling of batch processes. Comput Chem Eng 30(6–7):
913–946
27. Nie Y, Bielger LT, Wassick JM (2012) Integrated scheduling and
dynamic optimization of batch processes using state equipment
networks. AIChE J 58(11):3416–3432
28. Karlsson D, Jakobsson N, Axelsson A, Nilsson B (2004) Model-
based optimization of a preparative ion-exchange step for anti-
body purification. J Chromatogr A 1055:29–39
29. Muller-Spath T, Krattli M, Aumann L, Strohlein G, Morbidelli M
(2010) Increasing the activity of monoclonal antibody therapeu-
tics by continuous chromatography (MCSGP). Biotechnol Bioeng
107(4):652–662. doi:10.1002/bit.22843
30. Schmidt-Traub H (2012) Preparative chromatography, 2nd edn
edn. Wiley VCH, New York
31. Sherwood TK, Pigford RL, Wilke CR (1975) Mass transfer, vol
23. McGraw-Hill, New York
32. Melander WR, Rassi Z, Horvath C (1989) Interplay of hydro-
phobic and electrostatic interactions in biopolymer chromatog-
raphy: effect of salts on the retention of proteins. J Chromatogr A
469(3)
33. Harris JM, Martin NE, Mod M (2001) Pegylation, a novel process
for modifying pharmacokinetics. Clin Pharmacokinet 40(7):
539–551
34. Shampine LF, Reichelt MW (1997) The Matlab ODE Suite.
SIAM J Sci Comput 18(1):1–22
35. Davis ME (1984) Numerical methods and modeling for chemical
engineers. Wiley, New York
36. Mathworks (2012) Optimization toolbox—for use with MAT-
LAB. Natick, MA
Bioprocess Biosyst Eng
123